.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021929

« Back to Dashboard
NDA 021929 describes SYMBICORT, which is a drug marketed by Astrazeneca and is included in one NDA. It is available from two suppliers. There are thirteen patents protecting this drug. Additional details are available on the SYMBICORT profile page.

The generic ingredient in SYMBICORT is budesonide; formoterol fumarate dihydrate. There are nineteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the budesonide; formoterol fumarate dihydrate profile page.

Summary for NDA: 021929

Tradename:
SYMBICORT
Applicant:
Astrazeneca
Ingredient:
budesonide; formoterol fumarate dihydrate
Patents:13
Formulation / Manufacturing:see details

Pharmacology for NDA: 021929

Suppliers and Packaging for NDA: 021929

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SYMBICORT
budesonide; formoterol fumarate dihydrate
AEROSOL, METERED;INHALATION 021929 NDA AstraZeneca LP 0186-0370 0186-0370-20 1 POUCH in 1 CARTON (0186-0370-20) > 1 CANISTER in 1 POUCH > 120 AEROSOL in 1 CANISTER
SYMBICORT
budesonide; formoterol fumarate dihydrate
AEROSOL, METERED;INHALATION 021929 NDA AstraZeneca LP 0186-0370 0186-0370-28 1 POUCH in 1 CARTON (0186-0370-28) > 1 CANISTER in 1 POUCH > 60 AEROSOL in 1 CANISTER

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:AEROSOL, METERED;INHALATIONStrength0.08MG/INH;0.0045MG/INH
Approval Date:Jul 21, 2006TE:RLD:Yes
Patent:6,123,924Patent Expiration:Sep 26, 2017Product Flag?YSubstance Flag?Delist Request?
Patent:7,367,333Patent Expiration:Nov 11, 2018Product Flag?YSubstance Flag?Delist Request?
Patent:7,587,988Patent Expiration:Apr 10, 2026Product Flag?YSubstance Flag?Delist Request?

Expired Orange Book Patents for NDA: 021929

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca
SYMBICORT
budesonide; formoterol fumarate dihydrate
AEROSOL, METERED;INHALATION021929-001Jul 21, 20065,349,945► subscribe
Astrazeneca
SYMBICORT
budesonide; formoterol fumarate dihydrate
AEROSOL, METERED;INHALATION021929-002Jul 21, 20065,674,860► subscribe
Astrazeneca
SYMBICORT
budesonide; formoterol fumarate dihydrate
AEROSOL, METERED;INHALATION021929-001Jul 21, 20066,641,800► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc